Science Explorer Back to mapMap
Discussion
Company · Lincoln · United States

Celerion (United States)

celerion.comROR OpenAlex
Research works
92
▼ 48% vs 2018-21
Citations
1.8k
19.4 per fractional work
Top-10% rate
16.1%
all institutions 10.0%
Open access
56%
world 40%
International
32%
world 18%
Celerion (United States)

Not ranked overall: Celerion (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Celerion (United States) work in?

In all years, 61% of research at Celerion (United States) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (60%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (6%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 57 fractional works · 61.5% of its workMedicine: 55 fractional works · 59.9% of its workCardiology and Cardiovascular Medicine: 8 fractional works · 8.7% of its workInfectious Diseases: 6 fractional works · 6.3% of its workPhysiology: 6 fractional works · 6.2% of its workEpidemiology: 4 fractional works · 4.8% of its workPulmonary and Respiratory Medicine: 4 fractional works · 4.4% of its workOncology: 4 fractional works · 4.1% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 3.1% of its workHematology: 2 fractional works · 2.2% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 2.0% of its workPharmacology: 2 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.5% of its workSurgery: 1 fractional works · 1.5% of its workHepatology: 1 fractional works · 1.4% of its workNephrology: 1 fractional works · 1.4% of its workGenetics: 1 fractional works · 1.3% of its workNeurology: 1 fractional works · 1.2% of its workEmergency Medicine: 1 fractional works · 1.1% of its workRheumatology: 1 fractional works · 0.9% of its workOphthalmology: 1 fractional works · 0.8% of its workImmunology and Allergy: 1 fractional works · 0.8% of its workPsychiatry and Mental health: 1 fractional works · 0.7% of its workGastroenterology: 1 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 1 fractional works · 0.8% of its workNutrition and Dietetics: 1 fractional works · 0.8% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 24 fractional works · 26.2% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 15.1% of its workMolecular Biology: 11 fractional works · 12.1% of its workGenetics: 1 fractional works · 1.4% of its workCancer Research: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.7% of its workImmunology and Microbiology: 5 fractional works · 5.6% of its workImmunology: 4 fractional works · 4.0% of its workVirology: 2 fractional works · 1.6% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 3.3% of its workPharmacology: 2 fractional works · 2.4% of its workToxicology: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.5% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.8% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 10 fractional works · 10.3% of its workComputer Science: 2 fractional works · 2.4% of its workComputational Theory and Mathematics: 2 fractional works · 2.2% of its workComputer Networks and Communications: 0 fractional works · 0.2% of its workEngineering: 2 fractional works · 2.2% of its workElectrical and Electronic Engineering: 2 fractional works · 1.6% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 2 fractional works · 2.1% of its workOrganic Chemistry: 1 fractional works · 1.4% of its workAnalytical Chemistry: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 1.3% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.9% of its workWater Science and Technology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 1 fractional works · 1.0% of its workStatistics and Probability: 1 fractional works · 1.0% of its workPhysics and Astronomy: 1 fractional works · 0.9% of its workAtomic and Molecular Physics, and Optics: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 1.9% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.2% of its workEconomics and Econometrics: 1 fractional works · 1.2% of its workSocial Sciences: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.1% of its workALL ITS WORKCelerion (UnitedStates)92fractional works, all years
Life Sciences26%Physical Sciences10%Health Sciences61%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine5559.9%
    2. Nursing10.8%
    3. Health Professions00.3%
    4. Dentistry00.2%
    5. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology1415.1%
    2. Immunology and Microbiology55.6%
    3. Pharmacology, Toxicology and Pharmaceutics33.3%
    4. Neuroscience11.5%
    5. Agricultural and Biological Sciences10.8%
    1. Computer Science22.4%
    2. Engineering22.2%
    3. Chemistry22.1%
    4. Environmental Science11.3%
    5. Mathematics11.0%
    6. Physics and Astronomy10.9%
    7. Materials Science00.4%
    1. Economics, Econometrics and Finance11.2%
    2. Social Sciences00.4%
    3. Psychology00.3%
    4. Arts and Humanities00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.33× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 6.32× its world share, 1 worksImmunology and Micro…Neuroscience: 1.05× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 18.83× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.92× its world share, 0 worksChemistryComputer Science: 0.19× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringMathematics: 0.11× its world share, 0 worksMathematicsDentistry: 0.59× its world share, 0 worksDentistryMedicine: 3.31× its world share, 12 worksMedicineNursing: 2.47× its world share, 0 worksNursingVeterinary: 2.12× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 1.15× its world share, 0 worksEconomics, Econometr…Psychology: 0.28× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 18.8×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics18.83×1 works
  2. Immunology and Microbiology6.32×1 works
  3. Medicine3.31×12 works
  4. Nursing2.47×0 works
  5. Biochemistry, Genetics and Molecular Biology2.33×2 works
  6. Veterinary2.12×0 works
  7. Economics, Econometrics and Finance1.15×0 works
  8. Neuroscience1.05×0 works
  9. Chemistry0.92×0 works
  10. Dentistry0.59×0 works
  11. Psychology0.28×0 works
  12. Computer Science0.19×0 works
  13. Mathematics0.11×0 works
  14. Agricultural and Biological Sciences0.06×0 works
  15. Engineering0.05×0 works

Who are the top researchers at Celerion (United States)?

Ranked on the quality score, Sabina Paglialunga, Bruce H. Morimoto and Danielle R. Armas lead among researchers whose main affiliation is Celerion (United States).

  1. 1 Sabina Paglialunga United States · #819,021 worldwide 2.2k citations · 70 works
  2. 2 Bruce H. Morimoto United States · #1,719,797 worldwide 2k citations · 62 works
  3. 3 Danielle R. Armas United States · #1,839,429 worldwide 493 citations · 24 works
  4. 4 Edmund Venables United States · #1,904,044 worldwide 43 citations · 168 works
  5. 5 Mark J. Allison United States · #2,122,202 worldwide 661 citations · 17 works
  6. 6 Donald W. Graff United States · #2,198,863 worldwide 1.4k citations · 33 works
  7. 7 Laura M. Sterling United States · #2,245,542 worldwide 459 citations · 17 works
  8. 8 Caroline Engel United States · #2,383,633 worldwide 372 citations · 15 works
  9. 9 Allen Hunt United States · #2,425,234 worldwide 309 citations · 17 works
  10. 10 Terry E. O’Reilly United States · #3,236,070 worldwide 625 citations · 53 works
All ranked researchers at Celerion (United States)

What are the most cited papers from Celerion (United States)?

The most cited paper from Celerion (United States) is "Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial" (Adam L. Boxer et al., 2014), with 300 citations. Next come "Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor" (228) and "Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects" (154).

Most cited papers
#PaperReleasedCitations
1 Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial Adam L. Boxer et al. · The Lancet Neurology Open access 26 May 2014 300
2 Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor Jeanne Mendell, Hamim Zahir, Nobuko Matsushima et al. · American Journal of Cardiovascular Drugs Open access 19 Jun 2013 228
3 Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects Nobuko Matsushima, Frank Lee, Toshiyuki Sato et al. · Clinical Pharmacology in Drug Development 9 Sep 2013 154
4 Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A Thomayant Prueksaritanont, DA Tatosian, Xiaoyan Chu et al. · Clinical Pharmacology & Therapeutics 10 Dec 2016 144
5 A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers Grant C. O’Connell, John D. Pritchard, Chris Prue et al. · Internal and Emergency Medicine Open access 2 Feb 2019 114
All 60 most cited papers, with filters and sorting

Which keywords describe research at Celerion (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Antiretroviral Therapy, Arrhythmias, Ion Channels, Epidemiology, Cardiovascular Disease, Sudden Cardiac Death, Calcium Signaling and Monoclonal Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology8▲ 2.2×31 topics
  2. Antiretroviral Therapy6▲ 28×5 topics
  3. Cardiovascular Disease5▲ 5.0×16 topics
  4. Arrhythmias5▲ 37×2 topics
  5. Ion Channels4▲ 22×4 topics
  6. Inflammation4▲ 1.90×19 topics
  7. Sudden Cardiac Death4▲ 37×2 topics
  8. Calcium Signaling4▲ 33×4 topics
  9. Monoclonal Antibodies4▲ 29×3 topics
  10. HIV Infection4▲ 33×2 topics
  11. Immune Response4▲ 6.6×8 topics
  12. Pharmacokinetics4▲ 14×4 topics
  13. Cancer Risk4▲ 15×3 topics
  14. Psychiatric Disorders4▲ 26×2 topics
  15. Cardiac Electrophysiology4▲ 51×1 topic
  16. Long-QT Syndrome4▲ 51×1 topic
  17. Treatment4▲ 3.0×8 topics
  18. Hepatotoxicity3▲ 49×2 topics
  19. Health Consequences3▲ 19×2 topics
  20. Insulin Resistance3▲ 7.6×7 topics
  21. Drug Resistance3▲ 11×2 topics
  22. Smoking Cessation3▲ 101×1 topic
  23. Tobacco Use3▲ 101×1 topic
  24. Integrase Inhibitors3▲ 79×1 topic
  25. Nucleoside Analogues3▲ 79×1 topic
  26. Metabolic Syndrome3▲ 3.6×9 topics
  27. Biopharmaceuticals3▲ 44×3 topics
  28. Immunogenicity3▲ 57×3 topics
  29. Genetic Variation3▲ 8.9×2 topics
  30. Vaccine3▲ 7.1×5 topics
  31. Bioanalytical Methods2▲ 172×1 topic
  32. Biosimilars2▲ 172×1 topic
  33. Heart Failure2▲ 5.6×5 topics
  34. Medicinal Chemistry2▲ 6.7×3 topics
  35. Crystal Structure2▲ 9.4×2 topics
  36. HIV2▲ 18×2 topics
  37. Molecular Docking2▲ 15×1 topic
  38. Virtual Screening2▲ 31×1 topic
  39. Chronic Kidney Disease2▲ 8.3×5 topics
  40. Cognitive Function2▲ 10×2 topics

Which research topics does Celerion (United States) publish most on?

By volume in 2022-now: Cardiac electrophysiology and arrhythmias, Fibroblast Growth Factor Research, Pharmacogenetics and Drug Metabolism and Health Systems, Economic Evaluations, Quality of Life.

Cardiac electrophysiolog…1Cardiac electrophysiology and arrhythmias: 1 fractional worksFibroblast Growth Factor Research: 1 fractional worksPharmacogenetics and Drug Metabolism: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksECG Monitoring and Analysis: 0 fractional worksParkinson's Disease Mech…0Parkinson's Disease Mechanisms and Treatments: 0 fractional worksPsoriasis: Treatment and…0Psoriasis: Treatment and Pathogenesis: 0 fractional worksDermatology and Skin Dis…0Dermatology and Skin Diseases: 0 fractional worksCardiac pacing and defib…0Cardiac pacing and defibrillation studies: 0 fractional works
Cardiology and Cardiovascular MedicineMolecular BiologyPharmacologyEconomics and Econometrics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 1 works
  2. 2 Fibroblast Growth Factor Research Molecular Biology 1 works
  3. 3 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
  4. 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  5. 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  6. 6 ECG Monitoring and Analysis Cardiology and Cardiovascular Medicine 0 works
  7. 7 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  8. 8 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  9. 9 Dermatology and Skin Diseases Dermatology 0 works
  10. 10 Cardiac pacing and defibrillation studies Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.4%not open43.6%

World: 40% of research is openly available.

with international co-authors31.6%domestic only68.4%

World: 18% is written across borders.

How has Celerion (United States)'s research output changed?

Output in 2022-2025 was 48% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Celerion (United States) as a percentage of every work published that year, 0.000099% in 2024.

still counting0.00010%0.00020%0.00030%Celerion (United States)0.000065% in 202520102020

Fractional works of Celerion (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lincoln

All research institutions in Lincoln

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Celerion (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.